Adjusted One-Year Mortality Similar for On-, Off-Label TAVR

Share this content:
Adjusted One-Year Mortality Similar for On-, Off-Label TAVR
Adjusted One-Year Mortality Similar for On-, Off-Label TAVR

WEDNESDAY, June 21, 2017 (HealthDay News) -- Adjusted one-year mortality is similar for individuals undergoing transcatheter aortic valve replacement (TAVR) for on-label or off-label indications, according to a study published online June 21 in JAMA Cardiology.

Ravi S. Hira, M.D., from the University of Washington in Seattle, and colleagues examined patterns and adverse outcomes of off-label use of TAVR, defined as TAVR in patients with known bicuspid valve, moderate aortic stenosis, severe mitral regurgitation, severe aortic regurgitation, or subaortic stenosis, in U.S. clinical practice.

Off-label TAVR was used in 2,272 (9.5 percent) of the 23,847 patients in the study. The researchers found that patients receiving off-label TAVR had higher in-hospital mortality (6.3 versus 4.7 percent; P < 0.001), 30-day mortality (8.5 versus 6.1 percent; P < 0.001), and one-year mortality (25.6 versus 22.1 percent; P = 0.001), compared to those receiving on-label TAVR. The off-label group had higher adjusted 30-day mortality (hazard ratio, 1.27; 95 percent confidence interval, 1.04 to 1.55; P = 0.02), while adjusted one-year mortality was similar between the groups (hazard ratio, 1.11; 95 percent confidence interval, 0.98 to 1.25; P = 0.11). Per hospital, the median rate of off-label TAVR use was 6.8 percent, with increased 30-day adverse cardiovascular events for hospitals in the highest tertile of off-label use versus the lowest tertile.

"These results reinforce the need for additional research on the efficacy of off-label TAVR use," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text
Editorial 1 (subscription or payment may be required)
Editorial 2 (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Some California Mosquitoes Can Carry Zika Virus

Some California Mosquitoes Can Carry Zika Virus

Aedes aegypti mosquitoes found to transmit Zika virus

Periodontal Inflammation a Risk With Tongue Piercing

Periodontal Inflammation a Risk With Tongue Piercing

And, two young females with tongue piercings have deep lingual infrabony lesions, periodontitis

Risk of OD Highest for First Days of Opioid  Benzodiazepine Use

Risk of OD Highest for First Days of ...

Five-fold increased risk of opioid-related overdose during first 90 days of concurrent use

is free, fast, and customized just for you!




Already a member?

Sign In Now »